Literature DB >> 17508167

Caffeine and headaches.

R E Shapiro1.   

Abstract

Caffeine is the most widely consumed psychostimulant drug. It is a potent antagonist of adenosine receptors at dosages consistent with common dietary intake. With infrequent exposure, caffeine may act as an analgesic for headache or an adjuvant for the actions of other analgesics. With chronic repetitive intake, caffeine is associated with an increased risk of development of analgesicoveruse headache, chronic daily headache and physical dependency. Cessation of caffeine use following chronic exposures leads to a withdrawal syndrome, with headache as a dominant symptom.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508167     DOI: 10.1007/s10072-007-0773-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

Review 1.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

Review 2.  Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.

Authors:  Michele Ferrante; Kim T Blackwell; Michele Migliore; Giorgio A Ascoli
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  Caffeine induction of sulfotransferases in rat liver and intestine.

Authors:  Tianyan Zhou; Yue Chen; Chaoqun Huang; Guangping Chen
Journal:  J Appl Toxicol       Date:  2011-07-01       Impact factor: 3.446

Review 4.  A Clinical Approach to Addressing Diet with Migraine Patients.

Authors:  Margaret Slavin; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

Review 5.  Fasting headache.

Authors:  Paola Torelli; Gian Camillo Manzoni
Journal:  Curr Pain Headache Rep       Date:  2010-08

Review 6.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine.

Authors:  Kristian Agmund Haanes; Lars Edvinsson
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.

Authors:  Furqan H Tejani; Randall C Thompson; Rita Kristy; Stan Bukofzer
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-17       Impact factor: 2.357

9.  Caffeine discontinuation improves acute migraine treatment: a prospective clinic-based study.

Authors:  Mi Ji Lee; Hyun Ah Choi; Hanna Choi; Chin-Sang Chung
Journal:  J Headache Pain       Date:  2016-08-05       Impact factor: 7.277

10.  Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice.

Authors:  Aleksandra Szopa; Ewa Poleszak; Elżbieta Wyska; Anna Serefko; Sylwia Wośko; Aleksandra Wlaź; Mateusz Pieróg; Andrzej Wróbel; Piotr Wlaź
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.